Table 1.
Baseline characteristics of NSCLC patients new to SKCCC.
| Characteristic | Diagnosis or treatment (n = 67) | Consult only (n = 86) | Total (n = 153) | P value |
|---|---|---|---|---|
| Age, y <60 60–69 > = 70 |
26 (38.8) 21 (31.3) 20 (29.9) |
30 (34.9) 35 (40.7) 21 (24.4) |
56 (36.6) 56 (36.6) 41 (26.8) |
0.48 |
| Sex, % Male Female |
32 (47.8) 35 (52.2) |
44 (51.2) 42 (48.9) |
76 (49.7) 77 (50.3) |
0.68 |
| Race White Black Other |
46 (68.7) 16 (23.9) 5 (7.5) |
63 (73.3) 11 (12.8) 12 (14.0) |
109 (71.2) 27 (17.6) 17 (11.1) |
0.13 |
| Smoking status Never Former Current |
16 (23.9) 33 (49.3) 18 (26.9) |
24 (27.9) 52 (60.5) 10 (11.6) |
40 (26.1) 85 (55.6) 28 (18.3) |
0.05 |
| Stage and line of treatment Stage 1 or 2 Stage 3 Stage 4: first line therapy Stage 4: second line therapy or greater |
11 (16.4) 16 (23.9) 30 (44.8) 10 (14.9) |
4 (4.7) 11 (12.8) 25 (29.1) 46 (53.5) |
15 (9.8) 27 (17.6) 55 (35.9) 56 (36.6) |
<0.001 |
| Eligibility Ineligible Eligible |
41 (61.2) 26 (38.8) |
36 (41.9) 50 (58.1) |
77 (50.3) 76 (49.7) |
0.18 |